Gap junctions are transmembrane channels that allow the direct intercellular exchange of small molecules such as ions and second messengers to mediate communication between the adjacent cells (Loewenstein, 1981; Goodenough et al., 1996) . Each gap junction is composed of two hexamers of connexins (Cx) provided by the each of the adjacent cells. At least 20 distinct members of the Cx gene family including connexin 26, 32, 43 and 46 have been identified in mammals (Evans and Martin, 2002; Saez et al., 2003) .
Gap junctional intercellular communication (GJIC) is regulated by various physiological stimuli such as growth factors, protein kinases and oncogene products (Saez et al., 2003) . Among them, the tyrosine phosphorylation of Cx43 by the v-Src kinase, an oncogene product, represents a well investigated example of the regulation (Atkinson et al., 1981; Lampe and Lau, 2004; Warn-Cramer and Lau, 2004) . With paired Xenopus oocytes that express functional Cx43 and v-Src, Swenson et al. (1990) demonstrated that tyrosine phosphorylation of Cx43 was required for the inhibition of GJIC. Later investigations showed that tyrosine residues at positions 247 (Y247) and 265 (Y265) of Cx 43 were directly phosphorylated by v-Src. In addition, Cx43-disrupted cells expressing mutant forms of Cx43, in which either or both of Y247 and Y265 were replaced with phenylalanine, displayed normal GJIC even in the presence of v-Src (Lin et al., 2001 , Cottrell et al., 2003 .
Although tyrosine phosphorylation of Cx43 is critical for the disruption of GJIC, v-Src activates multiple signaling pathways including Ras, PI3 kinase and Stat3 that cause direct and indirect effects on a wide array of cellular function. Among these multiple signalings, Ras is one of the most characterized signaling pathways. Microinjection of a neutralizing antibody against Ras (Smith et al., 1986) or expression of a dominant-negative form of H-Ras (Feig and Cooper, 1988) could inhibit the cell growth and morphological change of v-Srctransformed cells. Similarly, p120 GAP , a negative regulator of Ras, showed suppressive effects on transformation by v-src (DeClue et al., 1991 , Nori et al., 1991 . Despite the importance of Ras signaling in cell transformation, it remains unclear whether Ras signaling is involved in the downregulation of GJIC by v-Src. In this paper, we show, for the first time, the involvement of Ras signaling in the downregulation of GJIC by v-Src.
A rat cell line, 3Y1, and 3Y1 transformed with v-Src (SR3Y1) were used throughout the study. We first examined the type of Cx expressed in these cells by RT-PCR. As shown in Figure 1a , Cx43, but not Cx26 or Cx32, was expressed in 3Y1 and SR3Y1. To examine the role of Ras signaling in the control of GJIC, we first established SR3Y1 in which S17N Ras is conditionally expressed under the control of mouse mammary tumor virus (MMTV) promoter/enhancer (S17N Ras SR). S17N Ras, a mutant Ras with Asn substitution for Ser at position 17 of H-Ras, yields a dominant inhibitory effect on endogenous Ras (Feig and Cooper, 1988) . Under the control of MMTV promoter/enhancer, S17N Ras was induced by treatment with dexamethasone.
Expression of S17N Ras did not suppress v-Src expression and tyrosine phosphorylation of cellular proteins (Figure 1b) . In contrast, the relative ratio of active Ras measured by pull-down assay was substantially decreased to the level similar to that of 3Y1 by dexamethasone treatment (Figure 1c) . To examine the effect of S17N Ras expression on Cx43 phosphorylation, similar amounts of Cx43 were immunoprecipitated from these cells and probed with antiphosphotyrosine antibody (Figure 1d ). While tyrosine phosphorylation of Cx43 in 3Y1 was undetectable, its phosphorylation in dexamethasone-treated S17N Ras SR was clearly detectable to the level similar to that of SR3Y1.
GJIC was measured by the transfer of Lucifer yellow dye. At 2 min after the computer-assisted microinjection of the dye into the parental cells, cells were fixed and the number of adjacent cells that become fluorescent was counted. As shown in Figure 1e and Figure 2 , junctional dye transfer in 3Y1 was always extensive. All cells adjacent to the injected cells showed clear spread of the dye. In contrast, dye transfer in SR3Y1 was almost completely abolished. Dye retained in the original microinjected cells without spreading. Without dexamethasone treatment, S17N Ras SR showed suppression of junctional dye transfer to the levels similar to those of parental SR3Y1. In contrast, GJIC of S17N Ras SR was dramatically restored by the treatment with 2 mM dexamethasone. It should be noted that only a single treatment with dexamethasone was enough to recover GJIC within 2 h. Interestingly, round morphology of cells as well as disruption of stress fiber formation remained unchanged under same condition ( Figure 2 ). In contrast, cells incubated for a day under the induction of S17N Ras showed the flat morphology, although the recovery of stress fiber formation was not clear.
To confirm these observations, we next explored the effect of mtGap1m expression on GJIC by use of tetracycline-dependent inducible system. Gap1m is a mammalian GTPase-activation protein for Ras. Gap1m is distinct from p120Gap and neurofibromin but has close similarity with Drosophila melanogaster Gap1 (Maekawa et al., 1994) . To make Gap1m protein to stably associate with membrane, C-terminal 20 aminoacid sequence of K-Ras was ligated to the C-terminal end of Gap1m (mtGap1m). mtGap1m was Myc-tagged in its N-terminal end. Full-length DNA of mtGap1m was ligated into pTet-splice expression vector and transfected together with pTet-Tak and pMAM2BSD into SR3Y1. Blasticidin-resistant colonies were selected and mtGap1m expression in the absence of tetracycline 
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v-Src suppresses gap junctions via Ras signaling S Ito et al
was probed by immunoblotting with anti-Myc antibody (Hamaguchi et al., 1993) . Figure 3a shows a representative clone, mtGap1m SR, which is a clear expression of mtGap1m in the absence of tetracycline. Expression of mtGap1m did not suppress v-Src expression and tyrosine phosphorylation of cellular proteins including Cx43 (Figure 3a and c) . In contrast, relative levels of active Ras measured by pull-down assay were substantially decreased by mtGap1m expression (Figure 3b ). Under these conditions, we examined the effect of mtGap1m expression on junctional dye transfer ( Figure  3d and e). In the presence of tetracycline, mtGap1m SR showed suppression of GJIC to the levels similar to those of parental SR3Y1. In contrast, expression of mtGap1m by the removal of tetracycline dramatically recovered GJIC in mtGap1m SR.
To confirm these observations further, we next examined the effect of manumycin A, a potent inhibitor of Ras farnesyltransferase (Hara et al., 1993) , on the control of GJIC by v-Src. While treatment of SR3Y1 with manumycin A did not suppress the expression of v-Src and Cx43 (Figure 4a ), relative Ras activity measured by pull-down assay in SR3Y1 was substantially reduced to the levels similar to those of 3Y1 (Figure 4b ). Tyrosine phosphorylation of Cx43 was not suppressed by the treatment with manumycin A (Figure 4c ). In contrast, the levels of junctional dye transfer in SR3Y1 were dramatically recovered by the drug treatment (Figure 4d and e) .
A large body of evidence demonstrates that unrestrained activation of the intracellular signaling pathways plays a critical role in the generation of tumors. The precise mechanisms of tumorigenesis by the activation of multiple signaling pathways are, however, still largely under investigation. Among multiple signaling molecules, Ras is one of the most characterized proteins, and numerous studies have been emphasizing its potent role in tumorigenesis. In this report, we showed the involvement of Ras signaling in the downregulation of GJIC by v-Src. The levels of junctional dye transfer in v-Src-transformed 3Y1 were substantially recovered by the conditional expression of either S17N Ras or mtGap1m, whereas tyrosine phosphorylation of Cx43 remained unchanged. Similarly, treatment of SR3Y1 with manumycin A dramatically recovered the levels of GJIC without suppressing the phosphorylation of Cx43. These results strongly suggest that, in addition to the tyrosine phosphorylation of Cx43, constitutive activation of Ras signaling is required for the suppression of GJIC by v-Src. It can be noted here that suppression of GJIC by the constitutively active form of Ras has been reported (Atkinson and Sheridan, 1984; Vanhamme et al., 1989) . Interestingly, under the brief induction of S17N Ras, GJIC substantially restored, whereas cell morphology as well as stress fiber formation remained unchanged. These results suggest that critical signaling for the control of GJIC may vary, in part, from those for the control of cell morphology and stress fiber formation.
Recently, activation of signal transducers and activators of transcription (Stat) 3, a Ras-independent signaling, was found to be involved in cell transformation by v-src (Yu et al., 1995; Cao et al., 1996; Bromberg et al., 1998; Turkson et al., 1999) . In contrast to Ras signaling, expression of dominant-negative Stat3 or siRNA against Stat3 could not recover GJIC in SR3Y1 (data Warn-cramer et al. (1996) reported that downregulation of GJIC by epidermal growth factor required phosphorylation of serine residues at positions 255, 279 and/or 282 of Cx43 by MAP kinase. Similarly, Zhou et al. (1999) reported that treatment of cells with PD98059, a chemical inhibitor for MEK1, prevented the downregulation of GJIC after the activation of temperature-sensitive form of v-Src in the temperatureshift experiment. Lin et al. (2001) , however, reported that treatment of v-Src-transformed cells with the MEK inhibitor failed to restore GJIC, although the treatment dramatically reduced the level of activated MAP kinase to approximately 5% of untreated cells. In our experiment, transient induction of S17N Ras did not completely suppress phosphorylation of MAPK, while GJIC was greatly recovered. In addition, we observed that expression of constitutively active form of MEK1 in 3Y1 did not suppress GJIC. Similarly treatment of SR3Y1 with MEK inhibitors such as U0126 and PD98059 did not restore GJIC. Recently, Cameron et al. (2003) also reported similar results. In the earlier studies, Ras was found to mediate its effects on cellular proliferation by activation of a linear cascade of kinases; Raf, MEK and MAP kinases (ERK1/2) which in turn regulates nuclear transcription factors including Elk-1 (Egan and Weinberg, 1993) . However, this pathway has been proven to be just a part of Ras signaling, and Ras signaling involves a complex array of signaling pathways including PI3 kinase, RalGDS, SEK-JNK, p120GAP, RIN1, NF1 GAP and AF6 (Campbell et al., 1998) . A further study to identify the downstream effector of Ras that controls GJIC remains to be identified.
